ARTICLE | Company News
Definiens, NeoGenomics deal
March 17, 2017 5:39 PM UTC
NeoGenomics and Definiens partnered to develop biomarker assays for clinical trials and routine clinical testing. The partners will use Definiens' Tissue Phenomics, an automated quantitative biomarker...